Robert Bitterman's Trading History
| PHIOPhio Pharmaceuticals | Sep 29, 2026 | Chairman, Pres. & CEO, Director | Uninformative Buy | ― | $657.79K | |
| FCSCFibrocell Science | ― | ― | ― | $0.00 |
You May Also Like
Robert Bitterman insider profile FAQ
What is the percentage of profitable transactions made by Robert Bitterman?
The percentage of profitable transactions made by Robert Bitterman is 0%.
What is the average return per transaction made by Robert Bitterman?
The average return per transaction made by Robert Bitterman is -52.70%.
What stocks does Robert Bitterman hold?
Robert Bitterman holds: PHIO, FCSC stocks.
What was Robert Bitterman's most profitable transaction?
Robert Bitterman’s most profitable transaction was an Informative Buy of PHIO stock on June 29, 2026. The return on the trade was -12.60%.
What is Robert Bitterman's role in Phio Pharmaceuticals?
Robert Bitterman's role in Phio Pharmaceuticals is Chairman, Pres. & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.